Recall Register

Food, drugs, devices › Becton Dickinson & Co.

Device recall: BBL Port A Cul tubes, catalog number 221606. Patient sample collection tubes. BBL Port A Cul tubes, jars and vials conta

FDA enforcement event 69954 · Class II · initiated 21 Nov 2014 · status Terminated · terminated 7 Jan 2016

DeviceVoluntary: Firm initiated2 product recordsSparks, MD

Becton Dickinson & Co. (Sparks, MD) initiated this device recall on 21 Nov 2014; FDA lists 2 product records under event 69954, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,176 device enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 7 Jan 2016. Initiation: voluntary: firm initiated. Becton Dickinson & Co. has 77 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Becton Dickinson & Co., Sparks, MD.

Reason for recall

"The products may exhibit indications of excessive oxidation. Excessive oxidation may affect the viability of anaerobic microorganisms."

Distribution

"US Nationwide distribution in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NV, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1746-2015BBL Port A Cul tubes, catalog number 221606. Patient sample collection tubes. BBL Port A Cul tubes, jars and vials contain a reduced transport medium and are intended to maintain the viability of anaerobic, facultative and aerobic microorganisms during transport from the patient to the laboratory. Sterile packages…145,860 tubesClass IITerminated17 Jun 2015
Z-1747-2015BBL Port A Cul tubes with Swabs Sterile Pack, catalog number 221607. For patient sample collection.92,710 unitsClass IITerminated17 Jun 2015

Context

91%of 2014 device events are Class II1,176 events that year
2product records in this eventfirm median: 1
77events on this register for the firm

Other enforcement events for Becton Dickinson & Co.

InitiatedProduct (first record)TypeClassRecords
7 Apr 2026BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic useDeviceClass II2
23 Oct 2025BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;DeviceClass II1
23 Sep 2025BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/G, Catalog NuDeviceClass II6
23 Jun 2025BD COR System Software. Model Number: 444829.DeviceClass II1
20 May 2025BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culDeviceClass II1
12 Feb 2025BD BBL TB Stain Kit K, Catalog (REF): 212522DeviceClass II1
19 Dec 2024BD PCR Cartridges used with MAX System. Model Number: 437519DeviceClass II1
6 Nov 2024BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) are used for semi-quantitatDeviceClass II1
31 Oct 2024BD EpiCenter Single User Software Version or Model: 441007 Catalog Number: 441007DeviceClass II13
12 Sep 2024BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory softDeviceClass II1

All 77 events for Becton Dickinson & Co.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The products may exhibit indications of excessive oxidation. Excessive oxidation may affect the viability of anaerobic microorganisms."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NV, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 7 Jan 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.